Although VEGFR2 has strong tyrosine kinase activity compared to VEGFR1 in endothelial cells, the level of VEGFR2 expression in MDA-MB-231 and MCF-7 breast cancer cells might not be sufficient to induce VEGF-mediated signaling in these cells. This evidence concerns the gene KDR and breast carcinoma.